Immune supplementation and immune modulation with intravenous immunoglobulin.
Mazer
Bruce D
BD
Meakins Christie Laboratories, McGill University, Montreal, Canada.
Al-Tamemi
Salem
S
Yu
Joyce W
JW
Hamid
Qutayba
Q
D004062:DiGeorge Syndrome / Q000628:therapy; D020275:Guillain-Barre Syndrome / Q000276:immunology / Q000628:therapy; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000276:immunology / Q000628:therapy; D016756:Immunoglobulins, Intravenous / Q000008:administration & dosage / Q000627:therapeutic use*; D007153:Immunologic Deficiency Syndromes / Q000276:immunology / Q000473:pathology / Q000628:therapy; D009080:Mucocutaneous Lymph Node Syndrome / Q000276:immunology / Q000473:pathology / Q000628:therapy; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000276:immunology / Q000473:pathology / Q000628:therapy
D016756:Immunoglobulins, Intravenous